Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that the Company will host an investor reception and webcast to discuss the development of its lead drug candidate, ganetespib, for the treatment of lung and breast cancers at the 2013 European Cancer Congress (ECCO-ESMO-ESTRO), which is taking place September 27 – October 1 in Amsterdam.
Help employers find you! Check out all the jobs and post your resume.
